SBW Life SciencesLtd Balance Sheet Health
Financial Health criteria checks 5/6
SBW Life SciencesLtd has a total shareholder equity of ₩35.6B and total debt of ₩35.0B, which brings its debt-to-equity ratio to 98.3%. Its total assets and total liabilities are ₩88.3B and ₩52.7B respectively.
Key information
98.3%
Debt to equity ratio
₩35.00b
Debt
Interest coverage ratio | n/a |
Cash | ₩25.90b |
Equity | ₩35.61b |
Total liabilities | ₩52.70b |
Total assets | ₩88.31b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: A151910's short term assets (₩42.5B) do not cover its short term liabilities (₩48.8B).
Long Term Liabilities: A151910's short term assets (₩42.5B) exceed its long term liabilities (₩3.9B).
Debt to Equity History and Analysis
Debt Level: A151910's net debt to equity ratio (25.5%) is considered satisfactory.
Reducing Debt: A151910's debt to equity ratio has reduced from 125.4% to 98.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A151910 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: A151910 has sufficient cash runway for 2 years if free cash flow continues to grow at historical rates of 42.6% each year.